ASCO GI Conference Coverage
Latest Articles
(Medscape Medical News) Jan 26, 2017 - Most cases of colorectal cancer are preceded by adenomas. Data show that chemoprevention with selective cyclooxygenase-2 (COX-2) inhibitors, particularly celecoxib (Celebrex, GD Searle), can reduce the incidence of these lesions.
Read Article
(4SC AG) Jan 24, 2017 - 4SC AG today announced that the study investigators presented the detailed scientific study analysis (abstract #252) from the multi-center, randomized, 170 patient Phase II study conducted by 4SC’s cooperation partner Yakult Honsha Co., Ltd. (Yakult Honsha) in Japan and South Korea at the 2017 Gastrointestinal...
Read Article
More Articles
January 25, 2017
January 25, 2017
January 23, 2017
January 23, 2017
January 23, 2017
January 23, 2017
January 23, 2017
January 19, 2017
View More
News Commentary
There is no ASCO GI Conference Coverage commentary.

OBR Green
There are no ASCO GI Conference Coverage OBR Green articles.
OBR Blog
By Emily Benesh, Ph.D., Analyst, Clinical & Scientific Assessment, Kantar Health and Stephanie Hawthorne, Ph.D.,... Read more
January 23, 2017
By Tari Awipi, Ph.D., Associate Consultant, Clinical & Scientific Assessment, Kantar Health and Jay Grisolano,... Read more
January 20, 2017